BRCA1 and cancer: Because CR itself is antagonistically pleiotropic (i.e. CR slows growth, development and reproduction -harmful early in life- and inhibits aging -beneficial later in life-), epidemiological and experimental approaches aimed to explore the impact of CR, CRMs and gerosuppressants such as metformin on the BRCA1-driven complex relationship between cancer & aging can be extremely informative.